Israeli drug-free nanomedicine breakthrough

(TIMES OF ISRAEL) In a breakthrough, scientists from the Technion-Israel Institute of Technology have engineered nanoparticles that treat aggressive “triple-negative” breast cancer tumours without chemotherapy or drugs, potentially paving the way for a chemical-free treatment for the deadly disease.

In a peer-reviewed study published in the journal ACS Nano, the researchers’ lab-engineered nanoparticles were able to halt the tumours in female mice.

The project was led by PhD candidate Ofri Vizenblit and assisted by Rawan Mhajne, under the supervision of Associate Professor Assaf Zinger, head of the Technion’s Bioinspired Nano Engineering Lab in the Wolfson Faculty of Chemical Engineering.

“We managed to design nanoparticles that got the same results as some advanced immunotherapy treatments currently in use,” Zinger told The Times of Israel.

“We had significant success.”